| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |